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Background
Epilepsy is a common, chronic neurological condition that af-
fects 50 million people worldwide. The risk of premature death
in people with epilepsy is up to three times higher than for
the general population making this disease a significant public
health concern. In England, there are around 3,100 deaths as-
sociated with epilepsy each year; 49 per cent of these deaths
are premature. The mortality of epilepsy in Wales in recent
years is currently unknown.
Main aim
To ascertain mortality figures for deaths associated with
epilepsy in Wales.
Method
We anonymously linked the Annual District Death Extract and
the Welsh Demographics Service datasets within the Secure
Anonymised Information Linkage Databank. Using ICD-10
codes for epilepsy, we identified all people who died with a
mention of epilepsy on their death certificate, date of their
death, and age at death between 2005 and 2017. Number
of deaths per year were summed for each year. We also cal-
culated the proportion of premature deaths and mean age at
death for each year. All-cause mortality figures were collated
as comparators.
Results
During the study period, there were around 173 deaths asso-
ciated with epilepsy in Wales each year. The proportion of
epilepsy-associated deaths compared with all-cause deaths in-
creased almost two-fold during this time. 54% of all deaths
associated with epilepsy occurred under the age of 75 years,
compared with 33 per cent of all-cause deaths. The mean age
at death for people with epilepsy is 67 years; 11 years younger
than all-cause deaths (78 years).
Conclusion
The number of deaths associated with epilepsy is increasing
every year in Wales. These figures also show that having
epilepsy reduces life expectancy. More research is needed into
the causes of epilepsy-associated deaths to inform policy and
improve outcomes for this patient group.
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